<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/abus" ></link>
<id>urn:uuid:71833c5b-8116-bb5f-a286-443406365763</id>
<updated>2026-10-01T11:53:23-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ABUS: ANDROSKI LINDSAY (PR,CEO,DIR) Exercised 126,864 Options (OE*) of ARBUTUS BIOPHARMA CORP for $3.20-$4.39 on 9/18, and Kept Some</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-6473046" ></link>
<id>urn:uuid:6ef3e05d-c0af-b1e4-289a-e6e875ba5b7c</id>
<updated>2026-09-23T20:32:24-04:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $4.85. Mkt Cap:960.8mm. 10D Vol: 5.5mm]]></summary>
</entry>
<entry>
<title>ABUS: NGUYEN TUAN (CFO) Exercised 293,100 Options (OE*) of ARBUTUS BIOPHARMA CORP for $3.49-$4.39 on 9/18, and Kept Some</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-6473048" ></link>
<id>urn:uuid:1cbd9a2f-95b2-d426-7a96-d5ca7c8ed276</id>
<updated>2026-09-23T20:31:52-04:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $4.85. Mkt Cap:960.8mm. 10D Vol: 5.5mm]]></summary>
</entry>
<entry>
<title>ABUS: SAWHNEY ROGER (DIR) Exercised 131,333 Options (OE*) of ARBUTUS BIOPHARMA CORP for $3.34-$4.24 on 9/18, and Kept Some</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-6473050" ></link>
<id>urn:uuid:ecfbbf82-0f6a-b3ac-8cf3-152c102f3928</id>
<updated>2026-09-23T20:31:17-04:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $4.85. Mkt Cap:960.8mm. 10D Vol: 5.5mm]]></summary>
</entry>
<entry>
<title>ABUS: BEARDSLEY ROBERT A (DIR) Exercised 131,333 Options (OE*) of ARBUTUS BIOPHARMA CORP for $3.20-$4.24 on 9/18, and Kept Some</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-6473052" ></link>
<id>urn:uuid:be18c897-aede-638d-ac94-5ba8ae43c534</id>
<updated>2026-09-23T20:31:01-04:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $4.85. Mkt Cap:960.8mm. 10D Vol: 5.5mm]]></summary>
</entry>
<entry>
<title>ABUS: NGUYEN TUAN (CFO) Acquired (JB) 73,500 Shares of ARBUTUS BIOPHARMA CORP for $0.00 on 2/2</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-6316764" ></link>
<id>urn:uuid:92aa65eb-633d-b0fc-f99a-cd72bf8378eb</id>
<updated>2026-02-02T20:21:34-05:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $4.85. Mkt Cap:960.8mm. 10D Vol: 5.5mm]]></summary>
</entry>
<entry>
<title>ABUS: ANDROSKI LINDSAY (PR,CEO,DIR) Acquired (JB) 28k Shares of ARBUTUS BIOPHARMA CORP for $0.00 on 2/2</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-6316765" ></link>
<id>urn:uuid:1a211eff-1421-5f30-7b39-5f621ef7d579</id>
<updated>2026-02-02T20:21:13-05:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $4.85. Mkt Cap:960.8mm. 10D Vol: 5.5mm]]></summary>
</entry>
</feed>